Cetuximab + / - Carboplatin for Estrogen Receptor-Negative, Progesterone Receptor-Negative Metastatic Breast Cancer
Clinical trial NCT00232505 · COMPLETED
Trial details
- NCT number
- NCT00232505
- Sponsor
- UNC Lineberger Comprehensive Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2010-06-21
- Enrollment
- 112
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.